Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central Germany, 2006-2016
- PMID: 31093923
- DOI: 10.1007/s15010-019-01317-2
Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central Germany, 2006-2016
Abstract
Purpose: NTM are ubiquitous bacteria that can cause colonisation and infection in immunocompetent and compromised hosts. The aim of this study was to elucidate the epidemiology of infection or colonisation with NTM for the metropolitan region of Frankfurt, Germany.
Methods: All patients from whom NTM were isolated within the period from 2006 to 2016 were included in this retrospective analysis. Patient data were retrieved using the local patient data management system. Different groups were formed according to clinical manifestations, underlying diseases and mycobacterial species. They were compared in regard to mortality, duration of infection/colonisation and their geographical origins.
Results: A total of 297 patients with a median of 28 new patients each year were included. Most patients suffered from lung infection or colonisation (72.7%, n = 216), followed by disseminated mycobacteriosis (12.5%, n = 37). The majority were HIV-positive, suffering from malignoma or cystic fibrosis (29.3%, n = 87, 16.2%, n = 48, and 13.8%, n = 41, respectively). 17.2% of patients showed no predisposing condition (n = 51). Mycobacterium avium complex (MAC) species were most frequently isolated (40.7%, n = 121). Infection/colonisation was longest in CF patients (median of 1094 days). The mortality was highest in malignoma patients (52.4%), while CF patients had the lowest overall mortality rate (5.3%). But mortality analysis showed non-significant results within different mycobacterial species and clinical manifestations.
Conclusion: NTM remain rare but underestimated pathogens in lung and disseminated disease. MAC were the species most frequently isolated. Depending on species and underlying predispositions, the duration of infection/colonisation can be unexpectedly long.
Keywords: Cystic Fibrosis; HIV; Mycobacterium abscessus complex; Mycobacterium avium complex; NTM; Non-tuberculous mycobacteria.
Similar articles
-
Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.Ann Am Thorac Soc. 2018 Jul;15(7):817-826. doi: 10.1513/AnnalsATS.201709-727OC. Ann Am Thorac Soc. 2018. PMID: 29897781 Free PMC article.
-
Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany.Int J Infect Dis. 2023 Apr;129:32-39. doi: 10.1016/j.ijid.2023.01.032. Epub 2023 Jan 31. Int J Infect Dis. 2023. PMID: 36736578
-
Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in Singapore.BMC Pulm Med. 2018 May 22;18(1):85. doi: 10.1186/s12890-018-0637-1. BMC Pulm Med. 2018. PMID: 29788943 Free PMC article.
-
Nontuberculous Mycobacterial Infections in Cystic Fibrosis.Clin Chest Med. 2016 Mar;37(1):83-96. doi: 10.1016/j.ccm.2015.11.001. Epub 2015 Dec 23. Clin Chest Med. 2016. PMID: 26857770 Review.
-
Nontuberculous Mycobacterial Infections in Cystic Fibrosis.Thorac Surg Clin. 2019 Feb;29(1):95-108. doi: 10.1016/j.thorsurg.2018.09.008. Thorac Surg Clin. 2019. PMID: 30454926 Review.
Cited by
-
Non-Tuberculous Mycobacterial Diseases in Children.Pathogens. 2020 Jul 9;9(7):553. doi: 10.3390/pathogens9070553. Pathogens. 2020. PMID: 32660053 Free PMC article. Review.
-
Long-term case-fatality rate of nontuberculous mycobacterial disease in people living with HIV.Infect Dis Poverty. 2022 Feb 7;11(1):16. doi: 10.1186/s40249-022-00942-8. Infect Dis Poverty. 2022. PMID: 35130974 Free PMC article.
-
Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control study.PLoS One. 2021 Jul 13;16(7):e0254607. doi: 10.1371/journal.pone.0254607. eCollection 2021. PLoS One. 2021. PMID: 34255788 Free PMC article.
-
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review.Clin Chest Med. 2023 Dec;44(4):675-721. doi: 10.1016/j.ccm.2023.08.012. Epub 2023 Sep 21. Clin Chest Med. 2023. PMID: 37890910 Free PMC article. Review.
-
Clinical and genomic features of Mycobacterium avium complex: a multi-national European study.Genome Med. 2024 Jul 9;16(1):86. doi: 10.1186/s13073-024-01359-8. Genome Med. 2024. PMID: 38982539 Free PMC article.
References
-
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An Official ATS/IDSA Statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. https://doi.org/10.1164/rccm.200604-571ST . - DOI - PubMed - PMC
-
- van Ingen J, Boeree MJ, van Soolingen D, Mouton JW. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat. 2012;15:149–61. https://doi.org/10.1016/J.DRUP.2012.04.001 . - DOI - PubMed
-
- Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Harris JK, Pace NR. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci USA. 2009;106:16393–9. https://doi.org/10.1073/pnas.0908446106 . - DOI - PubMed
-
- Falkinham JO, Iseman MD, de Haas P, van Soolingen D. Mycobacterium avium in a shower linked to pulmonary disease. J Water Health. 2008;6:209–13. https://doi.org/10.2166/wh.2008.032 . - DOI - PubMed
-
- van Ingen J, Kohl TA, Kranzer K, Hasse B, Keller PM, Katarzyna Szafrańska A, et al. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. Lancet Infect Dis. 2017. https://doi.org/10.1016/s1473-3099(17)30324-9 . - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical